Groombridge, Wu, Baughman & Stone LLP is a patent litigation firm. Our practice focuses on the intersection of science, technology and the law. Founded over two years ago, Groombridge, Wu, Baughman & Stone LLP is already widely recognized as one of the nation’s leading patent litigation firms. From small molecules to biologics, from manufacturing to purification to commercial scale-up, and in GPS, medical devices, semiconductors, and satellites, we have deep substantive expertise in both the law and in the science. The firm’s current docket reads like a tour of the most urgent scientific and commercial frontiers, including cases related to the Covid-19 vaccine, Wegovy®, cancer therapies, and cancer research and detection. Our lawyers are known for their rapport with juries and judges, for the care and devotion with which they approach their clients, for their scientific expertise, and for their thought leadership in patent law and policy. Since January 2024, Groombridge Wu has grown to 11 partners, including six women, added five former clerks from the Federal Circuit and one from the PTAB, and added a counsel in Tokyo. While many firms use size to project strength, Groombridge Wu has achieved national stature by focusing on results, client trust, and elite lawyering at every level.